RU2020122037A - Method for the treatment of acute respiratory viral infection - Google Patents

Method for the treatment of acute respiratory viral infection Download PDF

Info

Publication number
RU2020122037A
RU2020122037A RU2020122037A RU2020122037A RU2020122037A RU 2020122037 A RU2020122037 A RU 2020122037A RU 2020122037 A RU2020122037 A RU 2020122037A RU 2020122037 A RU2020122037 A RU 2020122037A RU 2020122037 A RU2020122037 A RU 2020122037A
Authority
RU
Russia
Prior art keywords
treatment
viral infection
acute respiratory
respiratory viral
respiratory
Prior art date
Application number
RU2020122037A
Other languages
Russian (ru)
Other versions
RU2020122037A3 (en
Inventor
Александр Ильич Антонов
Original Assignee
Александр Ильич Антонов
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Александр Ильич Антонов filed Critical Александр Ильич Антонов
Priority to RU2020122037A priority Critical patent/RU2020122037A/en
Publication of RU2020122037A3 publication Critical patent/RU2020122037A3/ru
Publication of RU2020122037A publication Critical patent/RU2020122037A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Claims (1)

Способ лечения острой респираторной вирусной инфекции, с использованием противопротозойного препарата, отличающийся тем, что, с целью повышения эффективности лечения и уменьшения токсичности процесса лечения, выбирают жидкую форму препарата, вводят его через носовую полость в дыхательные пути пациента в виде аэрозоля, который затем с помощью дыхательных движений распределяют по всей дыхательной системе.A method for the treatment of an acute respiratory viral infection using an antiprotozoal drug, characterized in that, in order to increase the effectiveness of treatment and reduce the toxicity of the treatment process, a liquid form of the drug is selected, it is injected through the nasal cavity into the respiratory tract of the patient in the form of an aerosol, which is then used respiratory movements are distributed throughout the respiratory system.
RU2020122037A 2020-06-29 2020-06-29 Method for the treatment of acute respiratory viral infection RU2020122037A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2020122037A RU2020122037A (en) 2020-06-29 2020-06-29 Method for the treatment of acute respiratory viral infection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2020122037A RU2020122037A (en) 2020-06-29 2020-06-29 Method for the treatment of acute respiratory viral infection

Publications (2)

Publication Number Publication Date
RU2020122037A3 RU2020122037A3 (en) 2021-12-29
RU2020122037A true RU2020122037A (en) 2021-12-29

Family

ID=80001040

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2020122037A RU2020122037A (en) 2020-06-29 2020-06-29 Method for the treatment of acute respiratory viral infection

Country Status (1)

Country Link
RU (1) RU2020122037A (en)

Also Published As

Publication number Publication date
RU2020122037A3 (en) 2021-12-29

Similar Documents

Publication Publication Date Title
MX2020010941A (en) Novel rsv rna molecules and compositions for vaccination.
PH12020551709A1 (en) Antiviral immunotropic agent for the treatment of acute respiratory viral infections
BRPI0609725B8 (en) nebulizer filter device and system for aerosolizing a drug
EA200800533A1 (en) PULSATING INHALER AND METHOD FOR TREATING DISEASES OF UPPER RESPIRATORY WAYS
RU2020122037A (en) Method for the treatment of acute respiratory viral infection
CN105311081A (en) Application of Shanhaidan chrysanthemum indicum injection in aerosol inhalation, spray bottle aerial fog and rectal administration and method
WO2021205026A3 (en) Pharmaceutical composition for treatment of enveloped dna or rna virus induced infections and disorders
RU2012116226A (en) Broncholytic agent based on prostaglandin
RU2010120806A (en) MONTELUKAST ACID INHALATION COMPOSITIONS AND PDE-4 INHIBITOR OR INHALATION CORTICOSTEROID
MX2020010977A (en) Methods of treating fungal infections.
RU2353376C1 (en) Method of bronchial pneumonia treatment and prevention in calves and piglets
RU2017140348A (en) Drug for the treatment of respiratory diseases in horses and method for its use
CN203852680U (en) Medical atomizing sprayer
US20210369835A1 (en) Method of Vaccination for SARS Virus
RU2020123217A (en) Anti-SARS-CoV-2 virus agent Antiprovir
RU2018144594A (en) A method for the treatment of respiratory failure syndrome in patients with acute ischemic stroke
RU2611374C1 (en) Means for polyps elimination in sinuses and prevention of their repeated growth and method of its application
RU2015138087A (en) The active ingredient of the drug, drug, pharmaceutical composition and method for the treatment of demyelinating diseases of a living organism, including disease prevention
KR20110008258U (en) Causes and treatment of cancer and adult diseases
Narwadkar et al. Role of Ignatia in Vocal Cord Dysfunction (VCD)
RU2022101386A (en) The use of a drug having an antiviral effect for the prevention or treatment of SARS-CoV-2 coronavirus infection (variants) and a method for the prevention or treatment of SARS-CoV-2 (infection)
CN106692335A (en) Method for treating bovine foot-and-mouth disease
RU2021128019A (en) METHOD FOR THE TREATMENT AND PREVENTION OF ACUTE RESPIRATORY VIRAL INFECTIONS
Turkmen et al. Founier gangrene–ozone therapy
RU2015131801A (en) GLUTARIMID DERIVATIVES, THEIR APPLICATION, PHARMACEUTICAL COMPOSITION BASED ON THEM, METHODS FOR PRODUCING THEM